Skip to content
中文产业新闻评分60Chinese source

礼来非共价BTK抑制剂匹妥布替尼在华获批慢性淋巴细胞白血病/小淋巴细胞淋巴瘤初治适应症

非共价BTK抑制剂首次进入一线!

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.